Filter
5898
Filtered Results: 5898
Text search:
drug
treatment
Featured
Recommendations
506
New Publications
1517
Language
Document type
No document type
3672
Studies & Reports
824
Guidelines
701
Manuals
233
Strategic & Response Plan
155
Fact sheets
115
Training Material
78
Situation Updates
58
Infographics
24
Resource Platforms
15
Brochures
14
Online Courses
7
App
1
Videos
1
Countries / Regions
India
368
Kenya
175
Global
165
South Africa
146
Western and Central Europe
131
Ethiopia
131
Uganda
123
Nigeria
112
Nepal
103
Tanzania
99
Liberia
93
Sierra Leone
89
Zambia
88
Malawi
87
Africa
83
Latin America and the Carribbean
78
Myanmar / Burma
74
Ghana
72
Bangladesh
72
Eastern Europe
71
Ukraine
65
Rwanda
61
Namibia
54
Philippines
49
Zimbabwe
47
Russia
45
Asia
42
Indonesia
41
Lesotho
38
Cambodia
37
South–East Asia Region
34
Mozambique
31
Botswana
30
Senegal
28
Congo, Democratic Republic of
27
Syria
26
Germany
25
Brazil
25
Eswatini/ Swaziland
23
Colombia
21
Burkina Faso
20
East and Southern Africa
20
South Sudan
20
Venezuela
17
West and Central Africa
17
USA
16
Middle East and North Africa
16
Cameroon
14
Eastern Europe and Central Asia
14
Haiti
13
Albania
12
Pakistan
12
Tajikistan
11
Guinea
11
Georgia
11
Thailand
10
Argentina
10
China
9
Afghanistan
9
Sudan
9
Peru
8
Vietnam
8
Yemen
7
North Macedonia
6
Benin
6
Armenia
6
Bolivia
6
Moldova
6
Angola
6
Mexico
5
El Salvador
5
Western Pacific Region
5
Lebanon
5
Papua New Guinea
5
Iraq
5
Somalia
5
Laos
4
Estonia
4
Guinea-Bissau
4
Jordan
4
Paraguay
4
Jamaica
4
United Kingdom
4
Southern Africa
4
Sri Lanka
4
Central African Republic
4
Libya
4
Bhutan
4
Ecuador
4
Timor Leste/ East Timor
3
Turkey
3
Iran
3
Fiji
3
Kyrgyzstan
3
Uzbekistan
3
Morocco
3
North America
3
Spain
3
Palestine
3
Mali
3
Switzerland
2
Serbia
2
Kazakhstan
2
Chile
2
Canada
2
Mongolia
2
Hungary
2
Saudi Arabia
2
Portugal
2
Belarus
2
Romania
2
Poland
2
Madagascar
2
North Korea
1
Australia
1
Gambia
1
Singapore
1
Malaysia
1
Qatar
1
Bulgaria
1
Italy
1
Lithuania
1
Ireland
1
Gabon
1
Uruguay
1
Turkmenistan
1
Denmark
1
Belgium
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Côte d’Ivoire / Ivory Coast
1
Egypt
1
Greece
1
Honduras
1
Chad
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
2234
Clinical Guidelines
556
Public Health
272
Women & Child Health
219
Key Resources
93
Capacity Building
92
Pharmacy & Technologies
59
Annual Report MEDBOX
1
Toolboxes
HIV
736
TB
677
Mental Health
634
AMR
282
COVID-19
240
NTDs
210
Pharmacy
179
NCDs
133
Caregiver
111
Ebola
93
Rapid Response
90
Refugee
83
Conflict
63
Planetary Health
62
Disability
60
Global Health Education
48
Health Financing Toolbox
29
Polio
23
Specific Hazards
19
Cholera
19
Natural Hazards
18
Zika
16
Social Ethics
15
Health Financing
1
This is a detailed manual giving a step by step approach to undertaking the pharmacovigilance of antiretrovirals. It is intended to be a source of practical advice for Pharmacovigilance Centres and health professionals involved in HIV/AIDS prevention and treatment programmes. A number of WHO publica...
The pamphlet "Oxycodone" provides an overview of the opioid drug class, explaining its uses, effects, and risks. It describes positive effects like euphoria and pain relief, alongside negative effects such as respiratory depression, confusion, and constipation. Withdrawal symptoms include anxiety, i...
Protocol for the management of specialized centres for the treatment of people with alcohol and other drug abuse problems (CETAD) in the framework of the COVID-19 pandemic. Version 1.
Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant
tuberculosis (XDR-TB) increasingly occur in resource-constrained settings.
In the context of a national response to MDR- and XDR-TB, health workers in
TB clinics (in district hospitals and some accredited health centres) wil...
After 100 years of chemotherapy with impractical and toxic drugs, an oral cure for human African trypanosomiasis (HAT) is available: Fexinidazole. In this case, we review the history of drug discovery for HAT with special emphasis on the discovery, pre-clinical development, and operational challenge...
This guide is a resource for physicians and other health care professionals who provide care and treatment to patients with drug-resistant tuberculosis.
This report provides an update on the key facets of HIV treatment access, including the latest HIV treatment guidelines from World Health Organization (WHO), an overview on pricing for first-line, second-line, and salvage regimens, and a summary of the opportunities for – and threats to – expand...
The World Health Organization's fact sheet on opioid overdose highlights the significant global health issue posed by opioids, which include natural, semi-synthetic, and synthetic compounds used primarily for pain management. Misuse and unsupervised use can lead to dependence and severe health probl...
The pamphlet "What is Addiction" explains addiction as a chronic, relapsing brain disease characterized by compulsive drug seeking and use, despite harmful consequences. It highlights the dangers of different drug categories, including sedatives, stimulants, and hallucinogens, and their potential he...
The Updated guidelines on Management of tuberculosis in children and adolescents include new recommendations that cover diagnostic approaches for TB, shorter treatment for children with non-severe drug-susceptible TB, a new option for the treatment of TB meningitis, the use of bedaquiline and delama...
Substance abuse, is a dangerous relapsing brain disease requiring intensive treatment in a professional setting. Someone who is suffering from substance abuse will have cravings and compulsive drug use that persists even in the face of negative consequences. Although substance abuse may start out as...
Following the encouraging initial results of the pilot project, the Ministry of Health is committed to increasing access to MDR-TB diagnosis, treatment and care. An expansion plan for the programmatic management of drug-resistant TB has been developed and forms part of the Five Year National Strateg...
Chagas disease affects approximately 6 million people, mainly in Latin America. Less than 1% of affected individuals receive proper antiparasitic treatment, and current drugs are inadequate to fight the entire spectrum of the disease. Against this background, Novartis is pursuing an end-to-end appro...
The WHO South-East Asia (SEA) Region bears a high burden of tuberculosis (TB) and MDR-TB. In 2015, the Region accounted for nearly 200 000 or 35% of the global estimated new RR/MDR-TB cases eligible for treatment. Extensively drug-resistant TB (XDRTB) has also been reported from s...
Version 10.1_5 October 2020
These Guidelines are available in different formats: As a paper booklet, a PDF, a mobile app, and now also as a website.
The 2019 version of the Guidelines introduces a new drug-drug interaction panel and now consists of six main sections, including a general overview ...
The control and elimination of schistosomiasis have over the last two decades involved several strategies, with the current strategy by the World Health Organization (WHO) focusing mainly on treatment with praziquantel during mass drug administration (MDA). However, the disease context is complex wi...
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spreading rapidly and require urgent solutions.
Gr...
The main objective of these guidelines is to provide guidance on up-to-date, uniform, evidence-informed practices for suspecting, diagnosing and managing various forms of extra-pulmonary tuberculosis (EPTB) at all levels of healthcare delivery. They can then contribute to the National Programme to i...
Tuberculosis (TB) is, and should be, a curable disease; however, each year significant numbers of patients acquire or develop drug-resistant TB, which has a much lower cure rate. Patients with drug-resistant TB have a high prevalence of symptoms; hence, staff caring for these patients should h...
It is essential that all people, including people living with HIV, are able to access health services and ongoing treatment. If people living with HIV who are on ART stop abruptly because they cannot access new supplies they could rapidly become unwell, drug resistance may build and the chances of o...
